Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 16, 2026
RE/MAX Holdings (RMAX) Eyes the $15 Level: +19.5% Upside Potential from Recent Close

RE/MAX Holdings (RMAX) Eyes the $15 Level: +19.5% Upside Potential from Recent Close

Key Takeaways

  • Selected price target: $15 per share, roughly 19.5% above RMAX’s latest close of $12.55.
  • Strongest bullish factor: The pending acquisition by The Real Brokerage values RMAX at $13.80 per share in cash or stock, creating a transaction-driven anchor of interest.
  • Biggest obstacle: That same $13.80 merger consideration may act as a near-term ceiling; reaching $15 likely requires improved terms, a higher stock-component value, or a standalone re-rating.
  • Key levels: Support appears in the $12.10–$12.30 area; resistance sits at the 52-week high of $13.35, followed by $13.80 and then $15.
  • Key takeaway: $15 is not the base-case expectation under current deal terms, but it is a realistic stretch scenario if transaction dynamics or operating momentum improve.

Why the $15 Level Stands Out

RMAX has already recovered sharply from its 52-week low of $5.46 set in April 2026 to a 52-week high of $13.35 in mid-August. With the stock consolidating just below that high, $15 stands out as the next major psychological threshold. The level has also appeared in public market commentary as a potential recovery objective, even though current published analyst targets generally sit lower.

Because $15 sits above both the 52-week high and the $13.80 per-share merger value, clearing that area would signal that the market sees value beyond the announced transaction—an important distinction for a stock trading with merger-driven dynamics.

Company Overview and Market Position

RE/MAX Holdings is a franchisor rather than a traditional brokerage owner. It generates revenue through real estate franchise fees and royalties under the RE/MAX brand, mortgage brokerage franchising through Motto Mortgage, loan-processing technology through wemlo, and marketing-fund programs. The company has a global footprint, with roughly 149,000 agents reported in early 2026.

Fundamentals remain mixed. Second-quarter 2026 revenue came in at $68.5 million, below consensus estimates of about $73.5 million, while adjusted earnings per share (EPS) of $0.32 also missed the roughly $0.39 consensus. Adjusted EBITDA of $22.9 million shows the franchise model still generates cash flow, but declining revenue and softer agent counts in the U.S. and Canada illustrate why a larger technology-enabled partner may be needed. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

The $13.80 Merger Anchor

In late April 2026, The Real Brokerage Inc. (NASDAQ: REAX) agreed to acquire RE/MAX Holdings in a cash-and-stock transaction. Each RMAX shareholder may elect to receive $13.80 in cash or 5.152 shares of the combined company, Real REMAX Group, subject to proration that caps total cash consideration between $60 million and $80 million. The deal is expected to close in the second half of 2026, subject to shareholder, regulatory, and court approvals.

The combined entity would have generated about $2.3 billion in pro forma 2025 revenue and about $157 million in adjusted EBITDA, with management targeting around $30 million in annual cost synergies by 2027. Those economics explain why RMAX has traded toward the $13.80 level—but they also explain why standalone upside above $13.80 is not currently the base case.

What Could Drive RMAX Toward $15

  • Stock-component appreciation: Because shareholders can elect 5.152 shares of Real REMAX Group, the value of that consideration can rise above $13.80 if the combined company’s shares outperform.
  • A superior proposal: A higher bid or revised terms could force the market to reprice RMAX beyond the current deal anchor.
  • Operating improvement: Better agent retention, stabilizing U.S. and Canadian fee revenue, or a broader housing recovery could support a higher standalone valuation.
  • Technical breakout: A decisive move through $13.35 and $13.80 would remove two visible resistance levels and could bring the psychological $15 area into focus.

What Could Prevent the Move

  • Deal ceiling: As long as the $13.80 consideration defines value, risk arbitrage may keep RMAX capped just below that level, adjusted for closing risk.
  • Fundamental softness: Revenue has been declining, and second-quarter results missed expectations, limiting the case for a standalone premium.
  • Industry headwinds: Commission-structure changes following the National Association of Realtors settlement, affordability pressures, and elevated mortgage rates continue to weigh on traditional real estate franchisors.
  • Analyst targets: Published 12-month price targets generally range from about $9 to $14.49, with consensus estimates below the $15 threshold.

Technical Levels That Matter

RMAX’s most important support zone sits near $12.10–$12.30, an area where the stock consolidated before its most recent push higher. Below that, the $11.30–$11.40 zone represents the early-August breakout area and a more significant demand zone. On the upside, $13.35 is the immediate 52-week high and the clearest near-term resistance. Above that, $13.80 is the merger-implied value, and $15 is the next major psychological target.

A sustained hold above $12.30 would keep the recent uptrend intact, while a decisive break below $11.30 would suggest the merger-related optimism is fading and put the focus back on the lower end of the range. From what I see, monitoring these levels closely helps frame the risk-reward around the $15 scenario.

Final Assessment

Can RE/MAX Holdings reach $15? The path exists, but it is more demanding than reaching the $13.80 transaction value. The strongest support comes from the merger, the company’s global franchise network, and the combined entity’s synergy potential. The largest obstacles are the deal-level anchor, softer revenue and earnings momentum, and a real estate industry still adjusting to commission and affordability pressures. Investors should monitor merger closing progress, the implied value of the stock consideration, quarterly agent-count and revenue trends, and whether RMAX can clear $13.35 on a closing basis. Until then, $15 remains a credible stretch scenario rather than the central expectation.

Tickeron AI Daily Buy/Sell Signals in My Research Process

I regularly turn to Tickeron’s AI Daily Buy/Sell Signals to stay on top of stocks like RMAX. The tool uses artificial intelligence to monitor thousands of securities and generate Buy, Sell, or Hold signals based on technical behavior and market conditions. It helps me place short-term price action around the $13.35 and $13.80 resistance levels in a broader, data-driven context without replacing my own analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RMAX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RMAX sees MACD Histogram just turned negative

RMAX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 26, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 37 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RMAX moved out of overbought territory on August 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 17 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 54 cases where RMAX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

The Aroon Indicator for RMAX entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 08, 2026. You may want to consider a long position or call options on RMAX as a result. In 68 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.463) is normal, around the industry mean (3.390). RMAX has a moderately high P/E Ratio (485.000) as compared to the industry average of (128.859). Projected Growth (PEG Ratio) (0.310) is also within normal values, averaging (0.672). Dividend Yield (0.019) settles around the average of (0.021) among similar stocks. P/S Ratio (0.909) is also within normal values, averaging (5.571).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RMAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Industry description

Activities range from the renovation and re-lease of existing buildings to the purchase of raw land and the sale of developed land or parcels to others. Demand for land development business is driven by GDP growth, employment rates, interest rates, and access to/cost of capital. For individual companies in this industry, proper cost estimation and successful bidding play critical roles in their profitability. Large companies could potentially have greater access to capital, while smaller companies can specialize in a specific geographic area or market niche. CBRE Group, VICI Properties Inc and Brookfield Property Partners L.P. are some of the large companies in this industry.

Market Cap

The average market capitalization across the Real Estate Development Industry is 2.67B. The market cap for tickers in the group ranges from 487 to 63.76B. IRSPF holds the highest valuation in this group at 63.76B. The lowest valued company is SHIOF at 487.

High and low price notable news

The average weekly price growth across all stocks in the Real Estate Development Industry was -2%. For the same Industry, the average monthly price growth was -9%, and the average quarterly price growth was 0%. EUDA experienced the highest price growth at 25%, while REAX experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Real Estate Development Industry was 75%. For the same stocks of the Industry, the average monthly volume growth was 64% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 70
Price Growth Rating: 63
SMR Rating: 82
Profit Risk Rating: 92
Seasonality Score: -28 (-100 ... +100)
View a ticker or compare two or three
RMAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of real estate brokerage services

Industry RealEstateDevelopment

Profile
Details
Industry
Real Estate Development
Address
5075 South Syracuse Street
Phone
+1 303 770-5531
Employees
544
Web
https://www.remax.com
Interact to see
Advertisement
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.
Shares of KC surged approximately +17% in premarket trading on March 18, 2026, from a prior close of $13.12 to approximately $15.35. The primary catalyst is Kingsoft Cloud's release of its unaudited Q4 and full-year 2025 financial results before the U.S. market open, which appear to have significantly exceeded analyst expectations.
AngloGold Ashanti (AU) shares tumbled approximately 7% in premarket trading on March 18, 2026, extending a multi-week downtrend that has erased nearly 20% of the stock's value since late January highs. The primary catalyst driving the decline is persistent investor concern over AngloGold's lowered 2026 production guidance, with the company projecting gold output of 2.80–3.17 million ounces — a roughly 3% decline from its 2025 production of 3.1 million ounces.
AAOI shares surged approximately 10.90% in premarket trading on March 18, 2026, rising from a prior close of $86.33 to $95.74. The primary catalyst is strong positive sentiment generated at OFC 2026 — the Optical Fiber Communications Conference and Exhibition — where Applied Optoelectronics unveiled breakthrough laser and transceiver technology for next-generation AI data center infrastructure.
LITE shares surged approximately +12% in early Wednesday trading on March 18, 2026, with the stock changing hands near $727 compared to a prior session close of $649.56. The primary near-term catalyst is Lumentum's S&P 500 index inclusion, effective March 23, 2026, triggering front-running by institutional investors and mandatory buying by passive index funds.
Shares of New Era Energy & Digital, Inc. (NUAI) are trading down approximately 17% during today's session, with the prior close sitting at $5.56. The decline follows the company's March 17 business update conference call and webcast, held after market hours, during which management discussed the recently filed fiscal year 2025 annual report (Form 10-K).
Shares of Regencell Bioscience Holdings (RGC) are up approximately +16% intraday on March 18, 2026, trading at $26.56 against a prior close of $22.97. No single company-specific press release is driving today's move; the rally is primarily fueled by retail-driven momentum and short squeeze mechanics.
A jump in the Producer Price Index from 0.3% to around 0.7% month‑over‑month signals that wholesale inflation is re‑accelerating, delaying Fed rate‑cut hopes and reviving the “higher for longer” rates narrative.business. Likely winners in this environment include energy and commodity producers (XOM, CVX, TTE, COP), inflation‑resilient financials (JPM, BAC), and real‑asset plays like pipelines and infrastructure, which can pass through higher prices; ETFs like XLE, XOP, XLF, DBA, GLD offer diversified exposure.
BGSI fell more than 11% today, pulling back from recent levels around the high‑$150s as investors reassessed the risk‑reward following the Q4 2025 print and major U.S. expansion plans. Full‑year 2025 sales rose 2.4% to US$3.14 billion, but same‑store sales declined 0.2%, while reported net earnings fell 25% to US$18.4 million due to US$22.6 million in acquisition and transformation costs.